Abstract LB-083: Combination of an ERK1/2 inhibitor (LY3214996) with pan-RAF inhibitor enhances anti-tumor activity inKRASmutant colorectal cancer (CRC) and non-small cell lung cancer (NSCLC)

Mapping Intimacies ◽

10.1158/1538-7445.sabcs18-lb-083 ◽

2019 ◽

Author(s):

Wenjuan Wu ◽

Shripad Bhagwat ◽

Lisa Kindler ◽

William McMillen ◽

Sajan Joseph ◽

...

Keyword(s):

Colorectal Cancer ◽

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anti Tumor Activity

Download Full-text

Abstract LB-083: Combination of an ERK1/2 inhibitor (LY3214996) with pan-RAF inhibitor enhances anti-tumor activity inKRASmutant colorectal cancer (CRC) and non-small cell lung cancer (NSCLC)

10.1158/1538-7445.am2019-lb-083 ◽

2019 ◽

Author(s):

Wenjuan Wu ◽

Shripad Bhagwat ◽

Lisa Kindler ◽

William McMillen ◽

Sajan Joseph ◽

...

Keyword(s):

Colorectal Cancer ◽

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anti Tumor Activity

Download Full-text

The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.

Journal of Cachexia Sarcopenia and Muscle ◽

10.1002/jcsm.12675 ◽

2020 ◽

Author(s):

Hidetaka Wakabayashi ◽

Hidenori Arai ◽

Akio Inui

Keyword(s):

Colorectal Cancer ◽

Gastric Cancer ◽

Lung Cancer ◽

Pancreatic Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Regulatory Approval ◽

Small Cell Lung

Download Full-text

Polyglutamate paclitaxel conjugate* is promising for the treatment of non-small-cell lung cancer and colorectal cancer,

Inpharma Weekly ◽

10.2165/00128413-200313910-00014 ◽

2003 ◽

Vol &NA; (1391) ◽

pp. 8

Author(s):

&NA;

Keyword(s):

Colorectal Cancer ◽

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung

Download Full-text

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

The Lancet Oncology ◽

10.1016/s1470-2045(08)70206-7 ◽

2008 ◽

Vol 9 (10) ◽

pp. 962-972 ◽

Cited By ~ 498

Author(s):

Helena Linardou ◽

Issa J Dahabreh ◽

Dimitra Kanaloupiti ◽

Fotios Siannis ◽

Dimitrios Bafaloukos ◽

...

Keyword(s):

Colorectal Cancer ◽

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Metastatic Colorectal Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Targeted Agents ◽

Small Cell Lung

Download Full-text

Abstract 5408: Enhancement of the anti-tumor activity of afatinib by inhibition of glycolysis in non-small cell lung cancer harboring the EGFR T790M mutation .

10.1158/1538-7445.am2013-5408 ◽

2013 ◽

Author(s):

Byoung Chul Cho ◽

Hyun-Jung Kim ◽

Sun Min Lim

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

T790m Mutation ◽

Inhibition Of Glycolysis ◽

Anti Tumor Activity ◽

Egfr T790m

Download Full-text

Abstract 753: Enhanced anti-tumor activity of erlotinib in combination with FAK tyrosine kinase inhibitors in non-small cell lung cancer

10.1158/1538-7445.am2014-753 ◽

2014 ◽

Author(s):

Grant A. Howe ◽

Bin Xiao ◽

Huijun Zhao ◽

Glenwood Goss ◽

Christina L. Addison

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Anti Tumor Activity

Download Full-text

Abstract 1678: Bioavailability and anti-tumor activity of capsaicin in human small cell lung cancer

10.1158/1538-7445.am2015-1678 ◽

2015 ◽

Cited By ~ 1

Author(s):

John D. Hurley ◽

William D. Rollyson ◽

Cody A. Stover ◽

Kathleen C. Brown ◽

Haley E. Perry ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anti Tumor Activity

Download Full-text

Abstract 5151: Nanoliposomal irinotecan (nal-IRI, MM-398) has greater anti-tumor activity than topotecan and irinotecan in mouse models of small cell lung cancer

10.1158/1538-7445.am2017-5151 ◽

2017 ◽

Author(s):

Shannon C. Leonard ◽

Daniel Gaddy ◽

Helen Lee ◽

Stephan Klinz ◽

Jonathan Fitzgerald ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Mouse Models ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Nanoliposomal Irinotecan ◽

Anti Tumor Activity

Download Full-text

Abstract 832: An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC

10.1158/1538-7445.am2018-832 ◽

2018 ◽

Cited By ~ 3

Author(s):

Louise A. Koopman ◽

Maarten L. Janmaat ◽

Kirstine Jacobsen ◽

Mikkel Green Terp ◽

Elke Gresnigt-van den Heuvel ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Specific Antibody ◽

Small Cell ◽

Egfr Inhibitor ◽

Small Cell Lung ◽

Antibody Drug Conjugate ◽

Anti Tumor Activity ◽

Antibody Drug

Download Full-text

A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer

Biochemical and Biophysical Research Communications ◽

10.1016/j.bbrc.2019.04.046 ◽

2019 ◽

Vol 513 (4) ◽

pp. 1083-1091 ◽

Cited By ~ 3

Author(s):

Muren Huhe ◽

Jiaxin Lou ◽

Yumeng Zhu ◽

Yu Zhao ◽

Ying Shi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Antibody Drug Conjugate ◽

Drug Conjugate ◽

Anti Tumor Activity ◽

Antibody Drug

Download Full-text